Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.42 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1049122 | 0.94 | ALDH1A1 (0.61) | ALDH1A1POLBKMT2ATLR8KCNH2 | |
| SCHEMBL6115033 | 0.94 | ALDH1A1 (0.61) | ALDH1A1POLBKMT2ATLR8KCNH2 | |
| SCHEMBL4361611 | 0.94 | ALDH1A1 (0.61) | ALDH1A1POLBKMT2ATLR8KCNH2 | |
| SCHEMBL2397143 | 0.92 | ALDH1A1 (0.59) | ALDH1A1POLBKMT2ATLR8KCNH2 | |
| Bromide SCHEMBL4479559 | 0.92 | ALDH1A1 (0.59) | ALDH1A1POLBKMT2ATLR8KCNH2 | |
| Water SCHEMBL28178859 | 0.92 | ALDH1A1 (0.59) | ALDH1A1POLBKMT2ATLR8KCNH2 | |
| SCHEMBL4226784 | 0.91 | ALDH1A1 (0.58) | ALDH1A1POLBKMT2ATLR8KCNH2 | |
| SCHEMBL4230811 | 0.91 | ALDH1A1 (0.58) | ALDH1A1POLBKMT2ATLR8KCNH2 | |
| SCHEMBL4225938 | 0.91 | ALDH1A1 (0.58) | ALDH1A1POLBKMT2ATLR8KCNH2 | |
| SCHEMBL16163775 | 0.91 | ALDH1A1 (0.58) | ALDH1A1POLBKMT2ATLR8KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2474527-B1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEM IND LTD (JP) | 2017-01-25 | — | — | EP | disclosed |
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | ALDH1A1 3717/4885POLB 3633/4885KMT2A 4633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.